15 results
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
conversions. ... using Table A ... Then using Table ... #Pharmacology #Pain ... Opiate #Opioid #Conversion
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Chart - Agents and Dosing ... Management #Pain #Pharmacology ... Equianalgesics #Conversion ... #Doses #Dosing ... #Table #PAMI
REBEL Review 46: Corticosteroid Conversion Chart 

Glucocorticoid, Approximate Equivalent Dose (mg), Relative Anti-Inflammatory (Glucocorticoid) Potency, Relative
Corticosteroid Conversion ... Approximate Equivalent Dose ... #endocrinology ... #comparison #table ... #pharmacology #
ACEI Antihypertensive Dose Comparison. Consider divided (BID) regimen for better pre-dose (trough) BP control for the
Antihypertensive Dose ... for better pre-dose ... ACEInhibitor #ACEIs #Dosing ... #Conversion #Pharmacology ... PrimaryCare #Comparison #Table
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
Conversions ... conversion that ... class is still going ... #Table #Dosing ... #Pharmacology #Dose
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
including tips for using ... dosage forms and conversion ... #pharmacology #antibiotics ... #medications #table
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... Inhibitors #Renal #Dosing ... #Pharmacology # ... Management #Diabetes #DM2 ... #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
GLP-1 receptor agonist ... Diabetes #Mellitus #DM2 ... #Medications #pharmacology ... #comparison #table ... #endocrinology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... GLP-I receptor agonist ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 # ... diabetes #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... Ozempic), or daily tablet ... Summary #DM2 #diabetes ... #endocrinology